William K. Grogan - 14 Sep 2026 Form 4 Insider Report for GE HealthCare Technologies Inc. (GEHC)

Reporting relationship: Chief Financial Officer
Issuer ticker: GEHC
Reported as of: 14 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 Sep 2026, 18:01:59 UTC
Prior SEC filing: 01 Sep 2026
Source filing: View source filing
Reporting owner signature: /s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact

Key filing fact

William K. Grogan filed Form 4 for GE HealthCare Technologies Inc. (GEHC) on 16 Sep 2026.

Key facts

This page summarizes William K. Grogan's Form 4 filing for GE HealthCare Technologies Inc. (GEHC).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 16 Sep 2026, 18:01.

Change

Previous filing in this sequence was filed on 01 Sep 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001694002 Primary reporting owner

Grogan William K

Relationship: Chief Financial Officer
Address: 500 W. MONROE STREET, CHICAGO
Signature: /s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact
Signature date: 16 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GEHC transaction

Common Stock, par value $0.01 per share

Award

Transaction value
Shares: +62,256
Change %
Price: $0.000000^*
Shares after: 62,256
Date: 14 Sep 2026
Ownership: Direct
Footnotes: F1, F2

GEHC transaction

Common Stock, par value $0.01 per share

Award

Transaction value
Shares: +12,840
Change %: +21%
Price: $0.000000^*
Shares after: 75,096
Date: 14 Sep 2026
Ownership: Direct
Footnotes: F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GEHC transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
Shares: +31,877
Change %
Price: $0.000000^*
Shares after: 31,877
Date: 14 Sep 2026
Ownership: Direct
Underlying class: Common Stock, par value $0.01 per share
Underlying amount: 31,877
Exercise price: $64.25
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on September 14, 2027, and 50% will vest on September 14, 2028.

Footnote F2

Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Footnote F3

Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029.

Footnote F4

Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.